Key stats
- Market cap
- 58.7B
- Open
- —
- Day range
- —
- 52-week range
- $74.66 – $104.50
- Volume
- 6.60M
- Avg volume
- 4.22M
Q3 FY26Upcoming
Expected$0.76
EW
Edwards Lifesciences Corporation$101.86+$6.67+7.01%Price as of Nov 4, 2026, 5:30 PM ET
Earnings
Q2 FY26
Actual$0.42
Q1 FY26
Actual$0.66
Q4 FY25
Actual$0.16
About
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
- Employees
- 16,000
- Headquarters
- Irvine, CA